Medmen Enterprises Class Stock Revenue
| MMNFFDelisted Stock | USD 0.0001 0.00 0.00% |
Medmen Enterprises Class fundamentals help investors to digest information that contributes to Medmen Enterprises' financial success or failures. It also enables traders to predict the movement of Medmen OTC Stock. The fundamental analysis module provides a way to measure Medmen Enterprises' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medmen Enterprises otc stock.
Medmen |
Medmen Enterprises Class OTC Stock Revenue Analysis
Medmen Enterprises' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Medmen Enterprises Revenue | 140.81 M |
Most of Medmen Enterprises' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medmen Enterprises Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Medmen Enterprises Class reported 140.81 M of revenue. This is 98.15% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is 98.51% higher than that of the company.
Medmen Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medmen Enterprises' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medmen Enterprises could also be used in its relative valuation, which is a method of valuing Medmen Enterprises by comparing valuation metrics of similar companies.Medmen Enterprises is currently under evaluation in revenue category among its peers.
Medmen Fundamentals
| Return On Asset | -0.0522 | |||
| Profit Margin | (1.04) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 390.25 M | |||
| Shares Outstanding | 1.3 B | |||
| Shares Owned By Insiders | 10.98 % | |||
| Shares Owned By Institutions | 2.97 % | |||
| Price To Book | 0.25 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 140.81 M | |||
| Gross Profit | 69.73 M | |||
| EBITDA | (106.73 M) | |||
| Net Income | (195.19 M) | |||
| Cash And Equivalents | 13.53 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 206.38 M | |||
| Debt To Equity | 7.54 % | |||
| Current Ratio | 0.50 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (62.53 M) | |||
| Earnings Per Share | (0.14) X | |||
| Target Price | 0.32 | |||
| Number Of Employees | 428 | |||
| Beta | 1.93 | |||
| Market Capitalization | 36.33 M | |||
| Total Asset | 323.22 M | |||
| Net Asset | 323.22 M |
About Medmen Enterprises Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medmen Enterprises Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medmen Enterprises using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medmen Enterprises Class based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Medmen Enterprises Class information on this page should be used as a complementary analysis to other Medmen Enterprises' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Medmen OTC Stock
If you are still planning to invest in Medmen Enterprises Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medmen Enterprises' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |